ArQule, Inc. (ARQL) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
ArQule, Inc. (ARQL)

An SI Board Since April 2003

Posts	SubjectMarks	Bans	Symbol
545	40	0	ARQL

Emcee: tuck	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
20	Hey Tuck, Welcome back. EOM.	keokalani'nui	-	8/6/2003
19	Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2674-8. Epub 2003 Feb 21. Selectiv	scaram(o)uche	-	8/6/2003
18	How many U'Prithcards are there in biotech? Andrea runs the CO501 program,	tuck	-	8/5/2003
17	that is the problem with this pony, too much burn done before real results are k	mopgcw	-	7/29/2003
16	Hi gang. With the cyclics reverse IPO, this company is substantially transforme	keokalani'nui	-	7/28/2003
15	bvf adds another 600 @ $3.90 bringing total to 2.42 million shares	mopgcw	-	7/28/2003
14	cc summary: Expect to close cyclics acq in 3q continue to transform to chemist	mopgcw	-	7/28/2003
13	ArQule Signs Agreement to Acquire Cancer Company Cyclis Pharmaceuticals Thursday	mopgcw	-	7/28/2003
12	Arqule Reports Second Quarter 2003 Financial Results Thursday July 24, 7:01 am	mopgcw	-	7/28/2003
11	Wasn't this part of the Camito acquisition? what's left? Inpharmatica	mopgcw	-	6/23/2003
10	ArQule's Small-Molecule Compound Shows Positive Response In Animal Model of	mopgcw	-	6/23/2003
9	Doesnt seem like a great bargain now- It will probably be a good 10 years before	Madharry	-	4/23/2003
8	Yes, I was thinking of redeploying my Evotec proceeds, but I'll wait for the	nigel bates	-	4/16/2003
7	market seems to like the report. up 11% at the moment; tried to get in pre-mkt	mopgcw	-	4/16/2003
6	ArQule Reports First Quarter 2003 Financial Results Wednesday April 16, 7:12 am	nigel bates	-	4/16/2003
5	I thought this PR at the end of last year was helpful: ArQule Announces Restruc	mopgcw	-	4/8/2003
4	I like it that some of their chemistry deals are royalty bearing (per 10K, and t	nigel bates	-	4/4/2003
3	A small clue beyond the 10-K: >>Bioorg Med Chem Lett 2002 Mar 11;12(5):77	tuck	-	4/4/2003
2	They expect both revenue and R&D to decrease as the transition to an early s	tuck	-	4/4/2003
1	The 10-K, just out, is an excellent place to start: sec.gov In a nutshell, the	tuck	-	4/4/2003

Go to reply# or date (mm/dd/yy):